These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 13518104

  • 1. [Mixed therapy of hyperthyroidism: combined thyroid antagonists and radiotherapy].
    LAROCHE G, BARRE Y, NOURY G.
    Presse Med (1893); 1958 Jan 08; 66(2):21-2. PubMed ID: 13518104
    [No Abstract] [Full Text] [Related]

  • 2. Antithyroid drugs plus roentgen irradiation in the treatment of hyperthyroidism.
    BOE J, GABRIELSEN Z.
    J Clin Endocrinol Metab; 1954 Aug 08; 14(8):939-47. PubMed ID: 13183987
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of Basedow's disease].
    IZAR G.
    Clin Ter; 1958 Jul 08; 15(1):3-16. PubMed ID: 13573647
    [No Abstract] [Full Text] [Related]

  • 4. [Medical treatment of hyperthyroidism].
    MAISTERRENA J, ROMERO F, NISENBAUM E, MARTINEZ S.
    Rev Invest Clin; 1957 Jul 08; 9(2-3):199-210. PubMed ID: 13485610
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of thyroid diseases.
    JACKSON AS.
    J Int Coll Surg; 1954 Mar 08; 21(3 1):344-50. PubMed ID: 13143258
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical experience with 1-methyl-2-mercaptoimidazol in the treatment of hyperthyroidism].
    FISCHER JT, TRAIBEL JA, DI LORENZO J, CORTES R.
    Arch Urug Med Cir Espec; 1953 Mar 08; 43(3-4):156-70. PubMed ID: 14350988
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of Basedow's disease with special reference to antithyroid substances and radioiodine.
    RIEDER W, HEYNE U.
    Bruns Beitr Klin Chir; 1958 May 08; 196(3):307-23. PubMed ID: 13546689
    [No Abstract] [Full Text] [Related]

  • 8. A four-year study of the treatment of hyperthyroidism with methimazole.
    CHEVALLEY J, McGAVACK TH, KENIGSBERG S, PEARSON S.
    J Clin Endocrinol Metab; 1954 Aug 08; 14(8):948-60. PubMed ID: 13183988
    [No Abstract] [Full Text] [Related]

  • 9. [The therapeutic problem of the combination of iodine and thyroxin with synthetic thyroid antagonists].
    LAROCHE G.
    Sem Hop; 1954 Feb 10; 30(11):652-3. PubMed ID: 13146179
    [No Abstract] [Full Text] [Related]

  • 10. Clinical experience with a new antithyroid drug: 2-carbethoxythio-1-methylglyoxaline.
    BARTELS EC.
    J Clin Endocrinol Metab; 1953 Nov 10; 13(11):1305-11. PubMed ID: 13108951
    [No Abstract] [Full Text] [Related]

  • 11. [Synthetic antithyroids].
    LUMBROSO P.
    Vie Med; 1954 Dec 10; 35(Spec No.):58-61. PubMed ID: 14359682
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Thyroid cancer discovered in two cases of hyperthyroidism apparently cured by antithyroids].
    BOULET P, MIROUZE J, BARJON P.
    Ann Endocrinol (Paris); 1953 Dec 10; 14(5):927-36. PubMed ID: 13139001
    [No Abstract] [Full Text] [Related]

  • 14. [Antithyroid drugs and radioiodine in therapy of hyperthyroidism].
    LINDEBOOM GA.
    Ned Tijdschr Geneeskd; 1953 Oct 24; 97(43):2827-8. PubMed ID: 13119776
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Use of thyroid antagonists in hyperthyroidism and thyroiditis].
    CHAPMAN GO.
    Arch Med Panamenos; 1952 Oct 24; 1(2):89-147. PubMed ID: 14944461
    [No Abstract] [Full Text] [Related]

  • 17. [Experience with the thyroid antagonist favistan].
    KLEINDL K.
    Med Klin; 1955 Apr 15; 50(15):672-4. PubMed ID: 14383176
    [No Abstract] [Full Text] [Related]

  • 18. Hyperthyroidism.
    Hashizume K, Suzuki S.
    Curr Ther Endocrinol Metab; 1997 Apr 15; 6():71-6. PubMed ID: 9174707
    [No Abstract] [Full Text] [Related]

  • 19. [Therapy of hyperthyroidism].
    Schumm-Draeger PM, Müller OA.
    Dtsch Med Wochenschr; 2003 Mar 07; 128(10):500-2. PubMed ID: 12627342
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.